DK1409449T3 - Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse - Google Patents

Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse

Info

Publication number
DK1409449T3
DK1409449T3 DK01983788T DK01983788T DK1409449T3 DK 1409449 T3 DK1409449 T3 DK 1409449T3 DK 01983788 T DK01983788 T DK 01983788T DK 01983788 T DK01983788 T DK 01983788T DK 1409449 T3 DK1409449 T3 DK 1409449T3
Authority
DK
Denmark
Prior art keywords
alpha
compositions
ketoglutarates
active ingredients
carnitines
Prior art date
Application number
DK01983788T
Other languages
English (en)
Inventor
Pietro Pola
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1409449T3 publication Critical patent/DK1409449T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Enzymes And Modification Thereof (AREA)
DK01983788T 2001-07-25 2001-10-29 Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse DK1409449T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000445A ITRM20010445A1 (it) 2001-07-25 2001-07-25 Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
PCT/IT2001/000549 WO2003010131A1 (en) 2001-07-25 2001-10-29 Alpha-ketoglutarates of active ingredients and compositions containing same

Publications (1)

Publication Number Publication Date
DK1409449T3 true DK1409449T3 (da) 2008-05-19

Family

ID=11455684

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01983788T DK1409449T3 (da) 2001-07-25 2001-10-29 Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse

Country Status (15)

Country Link
US (2) US20040192775A1 (da)
EP (1) EP1409449B1 (da)
AT (1) ATE383332T1 (da)
AU (1) AU2002215203B2 (da)
CA (1) CA2453516C (da)
CY (1) CY1107349T1 (da)
DE (1) DE60132374T2 (da)
DK (1) DK1409449T3 (da)
ES (1) ES2295223T3 (da)
HU (1) HUP0401572A3 (da)
IT (1) ITRM20010445A1 (da)
MX (1) MXPA04000754A (da)
PL (1) PL207586B1 (da)
PT (1) PT1409449E (da)
WO (1) WO2003010131A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087372B2 (en) 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7407770B2 (en) 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
WO2007082914A2 (en) * 2006-01-19 2007-07-26 Entress Ab Method of diagnosis and method of treatment
PL379512A1 (pl) * 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
WO2010005465A1 (en) * 2008-06-16 2010-01-14 Scian Laboratories, Llc L-carnitine and alkanoyl l-carnitine phytates and process for preparing the same
US8067468B2 (en) * 2009-06-10 2011-11-29 Jian Chen L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
HUE032165T2 (en) 2011-04-13 2017-09-28 Thermolife Int Llc Methods of using N-actyl-beta-alanine
AU2021377897A1 (en) 2020-11-12 2024-09-12 Thermolife International, Llc Methods of increasing blood oxygen saturation
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
KR20230145103A (ko) 2021-02-11 2023-10-17 써모라이프 인터내셔널, 엘엘씨 산화질소 기체의 투여 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150688B1 (en) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
IT1209564B (it) * 1984-06-29 1989-08-30 Magis Farmaceutici Derivati della l-carnitina o di l-acil carnitina.
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5270297A (en) * 1992-07-23 1993-12-14 Metagenics, Inc. Endurance and rehydration composition
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
DE19929993C2 (de) * 1999-06-30 2001-07-05 Sueddeutsche Kalkstickstoff Kreatin-alpha-ketoglutarate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
PT1409449E (pt) 2008-02-21
US7728037B2 (en) 2010-06-01
ATE383332T1 (de) 2008-01-15
HUP0401572A2 (hu) 2004-12-28
PL207586B1 (pl) 2011-01-31
EP1409449B1 (en) 2008-01-09
EP1409449A1 (en) 2004-04-21
PL367812A1 (en) 2005-03-07
US20040192775A1 (en) 2004-09-30
DE60132374T2 (de) 2008-12-24
WO2003010131A1 (en) 2003-02-06
CA2453516A1 (en) 2003-02-06
DE60132374D1 (de) 2008-02-21
US20060241181A1 (en) 2006-10-26
MXPA04000754A (es) 2004-07-08
CA2453516C (en) 2010-06-29
HUP0401572A3 (en) 2006-04-28
ITRM20010445A0 (it) 2001-07-25
ES2295223T3 (es) 2008-04-16
CY1107349T1 (el) 2012-12-19
AU2002215203B2 (en) 2008-04-10
ITRM20010445A1 (it) 2003-01-27

Similar Documents

Publication Publication Date Title
TW200505890A (en) Breast cancer-resistant protein inhibitor
CY1107349T1 (el) Αλφα-κετογλουταρικα ενεργα συστατικα και σκευασματα που τα περιεχουν
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BRPI0416292A (pt) composições estabilizadas compreendendo probióticos
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
TW200500348A (en) Biguanide and dihydrotriazine derivatives
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
BR0213536A (pt) Formulações de xarope de ribavirina
DE60200476D1 (de) Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen
UY27373A1 (es) Formulaciones de interferón beta-humano
ZA200501714B (en) Analogues of vitamin d
DK1289931T3 (da) Dobbeltsalte af fumarsyre med et carnitin og en aminosyre samt kosttilskud, diættilskud og lægemidler indeholdende samme
DK1202956T3 (da) Terapeutisk og/eller ernærngsmæssigt forstærkede derivater af aktive bestanddele og oralt indgivelsesbare præparater indeholdende de samme
MXPA03003799A (es) Composiciones solidas apropiadas para la administracion oral que contienen sales no higroscopicas de l-carnitina y l-carnitinas de alcanoilo con cloruro de taurina y cloruro de glicina.
DK1208078T3 (da) Ikke-hygroskopiske salte af aktive bestanddele der har terapeutiske og/eller ernæringsmæssige aktiveteter og sammensætninger til oral indgivelse der indeholder disse
BR9808461A (pt) Método para composições sólidas adequadas para administração oral compreendendo sais não higroscópicos de l-carnitina e alcanoil-l-carnitina com ácido 2-aminoetassulfÈnico.
PT1093451E (pt) Composicoes solidas adequadas para administracao oral contendo sais nao-higroscopicos de l-carnitina e alcanoil-l-carnitinas
ITMI20021366A1 (it) Composizioni nutraceutiche e integratori alimentari contenenti nadh
ITRM20010029A0 (it) Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse